Space Longevity @ Foresight Space Workshop ’23

David Furman, director of the 1000 Immunomes Project at Stanford, is at the forefront of space longevity research. Collaborating with NASA, Furman studies the risks associated with space flight and aging, aiming to develop countermeasures. Leveraging partnerships with SpaceX and Axiom, Furman collects biological data from astronauts during and after space flight. Using microgravity simulation, Furman’s team accelerates aging in organoids to study functional changes and identify drug candidates for age-related dysfunction. Access to space data and ground analogues helps map findings to diseases of aging. Furman also emphasizes the need to improve infrastructure for clinical trials in space.